Australia markets open in 9 hours 48 minutes

Vertex Pharmaceuticals Incorporated (VRTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
294.61-4.62 (-1.54%)
As of 10:11AM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
8,350,400
7,574,400
6,205,683
4,162,821
3,047,597
Cost of revenue
991,500
904,200
736,300
547,758
409,539
Gross profit
7,358,900
6,670,200
5,469,383
3,615,063
2,638,058
Operating expenses
Research development
3,349,300
3,051,100
1,829,537
1,754,540
1,416,476
Selling general and administrative
883,900
840,100
770,456
658,498
557,616
Total operating expenses
4,233,200
3,891,200
2,599,993
2,413,038
1,974,092
Operating income or loss
3,125,700
2,779,000
2,869,390
1,202,025
663,966
Interest expense
59,800
61,500
58,151
58,502
34,119
Total other income/expenses net
852,300
8,000
283,320
187,718
-29,606
Income before tax
3,932,900
2,730,400
3,116,798
1,394,919
600,241
Income tax expense
738,300
388,300
405,151
218,109
-1,486,862
Income from continuing operations
3,194,600
2,342,100
2,711,647
1,176,810
2,087,103
Net income
3,194,600
2,342,100
2,711,647
1,176,810
2,096,896
Net income available to common shareholders
3,194,600
2,342,100
2,711,647
1,176,810
2,096,395
Basic EPS
-
9.09
10.44
4.58
8.24
Diluted EPS
-
9.01
10.29
4.51
8.09
Basic average shares
-
257,700
259,841
256,728
254,292
Diluted average shares
-
259,900
263,396
260,673
259,185
EBITDA
-
2,917,500
3,284,464
1,560,362
706,780